Pollinil 6 X Tablet is a Health Canada–registered human drug (DIN 02243473) held by Dolisos Laboratoires S.a., containing Apis Mellifica. Health Canada lists its status as Cancelled Post Market (status date 01 Aug 2007). Nexara Health has matched 20 registrations of Apis Mellifica across 3 other regulated markets, 1 of them in the same strength and dosage form.
Health Canada registration
| DIN | 02243473 |
|---|---|
| Brand name | Pollinil |
| Active ingredient | Apis Mellifica |
| Strength | 6 X |
| Dosage form | Tablet |
| Route | Oral |
| Company | Dolisos Laboratoires S.a. |
| Status | Cancelled Post Market — 01 Aug 2007 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Apis Mellifica registered in other markets
20 registrations of the same molecule in 3 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Bestmade Natural Products Apis Mellifica | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| Netherlands | Apis mellifica | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Apis mellifica | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United Arab Emirates | Apis mellifica - Dr. Reckeweg | PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO. GMBH, Germany, BENSHEIM | MT - 200C | Drops | Active | EDE |
| United States | Apis Cord | Energique, Inc. | Liquid | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC | |
| United States | Apis Mellifica | Hahnemann Laboratories, Inc | Pellet | listed | FDA NDC |
See every manufacturer of Apis Mellifica worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Pollinil (DIN 02243473) marketed in Canada?
No. Health Canada lists DIN 02243473 as Cancelled Post Market as of 01 Aug 2007.
Who holds the Canadian licence for this product?
Dolisos Laboratoires S.a. is the company of record in the Health Canada Drug Product Database.
Is Apis Mellifica registered outside Canada?
Yes — Nexara Health has matched 20 registrations in 3 other markets, including 1 in the same strength and dosage form (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02243473, status date 2007-08-01; national medicine registries: EDE, EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02243473, status date 2007-08-01; national medicine registries: EDE, EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02243473, status date 2007-08-01; national medicine registries: EDE, EU national register, FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.